ENTITY
ER-100
ER-100
PulseAugur coverage of ER-100 — every cluster mentioning ER-100 across labs, papers, and developer communities, ranked by signal.
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-09-08 product_launch A gene therapy for age-related vision loss, ER-100, developed by Yuancheng (Ryan) Lu, has entered human clinical trials. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Geneticist's age-reversal eye therapy enters human trials
Yuancheng (Ryan) Lu, a geneticist at the Whitehead Institute, has developed a gene therapy that shows promise in reversing age-related vision loss. His technique, based on reprogramming cells using a modified set of Yam…
-
Life BioSciences begins Phase 1 trial for optic neuropathy drug
Life BioSciences has announced a significant milestone with the first patient dosed in a Phase 1 clinical trial for ER-100, an epigenetic restoration drug candidate. This drug targets optic neuropathies, a group of diso…